Literature DB >> 6181207

Biochemical characterisation and localization in brain of a human brain-leucocyte membrane glycoprotein recognised by a monoclonal antibody.

J L McKenzie, R Dalchau, J W Fabre.   

Abstract

The F10-44-2 monoclonal antibody was originally shown to interact with a determinant found predominantly in human brain and leucocytes. In this study we demonstrate by quantitative absorption analysis with homogenates of the head of the caudate nucleus, putamen, thalamus, cerebral grey matter, cerebral white matter, corpus callosum and cerebellar folia that the determinant is restricted to the white matter of the CNS. Immunofluorescence studies on frozen sections of the above brain subregions confirm the absorption analyses, showing staining only of white matter. In addition, and unexpectedly, we found very bright staining around blood vessels, particularly in the cerebellum. Biochemical studies established that the molecule in white matter bearing the F10-44-2 determinants is a sialylated membrane glycoprotein with an apparent molecular weight of 90,000, which is similar to but slightly smaller than the T lymphocyte form of the antigen. Developmental studies comparing 16-week foetal and adult cerebrum showed a fivefold increase in F10-44-2 antigen content. Thus, in the human CNS, the F10-44-2 antigen is a medium-sized glycoprotein which is restricted to white matter and shows a marked increase in concentration during development. No such molecule has been described previously.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181207     DOI: 10.1111/j.1471-4159.1982.tb12592.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44.

Authors:  M P Shepley; V R Racaniello
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

2.  Purification and characterization of the P-80 glycoprotein from human brain.

Authors:  N Girgrah; T F Cruz; M Letarte; M A Moscarello
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

3.  Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood.

Authors:  M J Dobersen; P Gascon; S Trost; J A Hammer; S Goodman; A B Noronha; D J O'Shannessy; R O Brady; R H Quarles
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Purification and characterization of a protein antigen (p94) from human brain and its identification in other species.

Authors:  T F Cruz; N Girgrah; E J Quackenbush; M Letarte; M A Moscarello
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

5.  Identification of three antigens in human brain associated with similar antigens on human leukaemic cells.

Authors:  E J Quackenbush; T F Cruz; M A Moscarello; M Letarte
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

6.  Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.

Authors:  V A Brown; S K Smith; A E Dewar; G Stockdill; A H Maddy
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

7.  Structural heterogeneity of human Pgp-1 and its relationship with p85.

Authors:  M B Omary; I S Trowbridge; M Letarte; M F Kagnoff; C M Isacke
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  Monoclonal antibody cross-reactions between Drosophila and human brain.

Authors:  C A Miller; S Benzer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  Chemical composition and tissue distribution of the human CDw44 glycoprotein.

Authors:  B F Flanagan; R Dalchau; A K Allen; A S Daar; J W Fabre
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

10.  Extracellular matrix hyaluronan signals via its CD44 receptor in the increased responsiveness to mechanical stimulation.

Authors:  L F Ferrari; D Araldi; O Bogen; J D Levine
Journal:  Neuroscience       Date:  2016-03-18       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.